The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease-Reference-Cited by-同舟云学术

The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease

Published:2008-08 Issue:4 Volume:74 Page:495-504
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Eardley Kevin S.,Kubal Chandrashekhar,Zehnder Daniel,Quinkler Marcus,Lepenies Julia,Savage Caroline O.,Howie Alec J.,Kaur Kirrenjit,Cooper Mark S.,Adu Dwomoa,Cockwell Paul

Publisher

Elsevier BV

Subject

Nephrology

Reference36 articles.

1. Macrophages and progressive tubulointerstitial disease;Sean Eardley;Kidney Int,2005

2. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease;Eardley;Kidney Int,2006

3. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment;Grandaliano;J Am Soc Nephrol,1996

4. Blockade of CCR2 ameliorates progressive fibrosis in kidney;Kitagawa;Am J Pathol,2004

5. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis;Prodjosudjadi;Clin Nephrol,1995

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum soluble interleukin-2 receptor alpha may predict tubulointerstitial inflammatory cell infiltration and short-term disease progression in immunoglobin A nephropathy;Immunologic Research;2024-09-14

2. Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease;Cell Communication and Signaling;2024-07-05

3. Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets;International Journal of Molecular Sciences;2024-01-26

4. Dual soluble epoxide hydrolase inhibitor – farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis;Frontiers in Immunology;2024-01-03

5. Clinical efficacy of beraprost sodium in treating chronic kidney disease: A six-month prospective study;Heliyon;2024-01